Drug companies have quietly stepped back from development programs in long COVID and related conditions, leaving patients ...

Caitlin Fowler took on a lofty charity challenge to go the distance for partner Lucy Stewart who has a rare lifechanging auto ...

The estate of a Cheshire man is suing several Connecticut healthcare providers, contending doctors failed to diagnose the ...

There is a push to reduce the demand for the plasma-derived therapy, as patients, physicians and governments worry about ...

Myasthenia gravis affects about 30 out of every 100,000 people in Canada, according to the Myasthenia Gravis Society of ...

Detailed price information for Amarin Corp ADR (AMRN-Q) from The Globe and Mail including charting and trades.

On Feb. 26, 2024, he suffered acute respiratory failure and cardiac arrest and his family found him unresponsive.

Jacob Funds, a mutual fund company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded ...

Vor Biopharma pivots to telitacicept for autoimmune diseases, backed by $491M cash to 2029. Click here to read an analysis of ...

J&J presents new Imaavy data at EAN 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis: Geneva Monday, June 29, 2026, 18:00 Hrs [IST] Johnson & J ...

Johnson & Johnson (NYSE: JNJ) today announced new data across 12 abstracts at the European Academy of Neurology (EAN) 2026 Congress that offer additional insight into the use of IMAAVY® ...